Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: A phase II-study and historical comparison with the surgical approach
Authors:
- Bert HildebrandtBHBert Hildebrandt
- Maciej PechMPMaciej Pech
- Annett NicolaouANAnnett Nicolaou
- Jan M LangrehrJLJan M Langrehr
- Jacek KurczJKJacek Kurcz
- Birgit BartelsBBBirgit Bartels
- Alexandra MierschAMAlexandra Miersch
- Roland FelixRFRoland Felix
- Peter NeuhausPNPeter Neuhaus
- Hanno RiessHRHanno Riess
- Bernd DörkenBDBernd Dörken
- Jens RickeJRJens Ricke
Open Access
- 24 April 2007
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 69
Abstract
The high complication rates of surgically implanted port catheter systems (SIPCS) represents a major drawback in the treatment of isolated liver neoplasms by hepatic arterial infusion (HAI) of chemotherapy. Interventionally implanted port catheter systems (IIPCS) have evolved into a promising alternative that enable initiation of HAI without laparatomy, but prospective data on this approach are still sparse. Aim of this study was to evaluate the most important technical endpoints associated with the use of IIPCS for the delivery of 5-fluorouracil-based HAI in patients with colorectal liver metastases in a phase 2-study, and to perform a non-randomised comparison with a historical group of patients in which HAI was administered via SIPCS. 41 patients with isolated liver metastases of colorectal cancer were enrolled into a phase II-study and provided with IIPCS between 2001 and 2004 (group A). The primary objective of the trial was defined as evaluation of device-related complications and port duration. Results were compared with those observed in a pre-defined historical collective of 40 patients treated with HAI via SIPCS at our institution between 1996 and 2000 (group B). Baseline characteristics were balanced between both groups, except for higher proportions of previous palliative pre-treatment and elevated serum alkaline phosphatase in patients of group A. Implantation of port catheters was successful in all patients of group A, whereas two primary failures were observed in group B. The frequency of device-related complications was similar between both groups, but the secondary failure rate was significantly higher with the use of surgical approach (17% vs. 50%, p < 0.01). Mean port duration was significantly longer in the interventional group (19 vs. 14 months, p = 0.01), with 77 vs. 50% of devices functioning at 12 months (p < 0.01). No unexpected complications were observed in both groups. HAI via interventionally implanted port catheters can be safely provided to a collective of patients with colorectal liver metastases, including a relevant proportion of preatreated individuals. It appears to offer technical advantages over the surgical approach.Keywords
This publication has 26 references indexed in Scilit:
- Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481)Journal of Clinical Oncology, 2006
- Fusion imaging using a hybrid SPECT-CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Is There a New Drug Beyond Floxuridine for Intra-Arterial Hepatic Chemotherapy in Liver Metastases From Colorectal Cancer?Journal of Clinical Oncology, 2005
- Hepatic Arterial Port Systems for Treatment of Liver Metastases: Factors Affecting Patency and Adverse EventsJournal of Vascular and Interventional Radiology, 2004
- A Systematic Review of Hepatic Artery Chemotherapy After Hepatic Resection of Colorectal Cancer Metastatic to the LiverDiseases of the Colon & Rectum, 2004
- Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinomaCancer, 2004
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerNew England Journal of Medicine, 1999
- Randomized Trial of Surgery Versus Surgery Followed by Adjuvant Hepatic Arterial Infusion With 5-Fluorouracil and Folinic Acid for Liver Metastases of Colorectal CancerAnnals of Surgery, 1998
- Minimally invasive catheter implantation for regional chemotherapy of the liver: A new percutaneous transsubclavian approachCardioVascular and Interventional Radiology, 1997
- Reappraisal of Hepatic Arterial Infusion in the Treatment of Nonresectable Liver Metastases From Colorectal CancerJNCI: Journal of the National Cancer Institute, 1996